Skip to main content
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

CDC Admits Massive Problems With PCR Tests, Even Worse Tests On The Way?


The CDC recently admitted that PCR tests were completely unreliable…

Originally they cited the fact that PCR tests could stay positive for up to 12 weeks; this alone was bad enough, but now there is an even worse problem.

According to our previous reports, the agency now admits that PCR tests really cannot differentiate between Covid-19 and the flu.

This is a massive problem as whole economies were shut down due to the responses from these extremely faulty tests…

If that wasn’t bad enough, instead of just scrapping the whole testing thing altogether, The CDC wants to use new and novel forms of testing.

My question is if they failed massively before—for 2 straight years, why should these new and novel tests with zero use history, data, and diagnostic reports be trusted at all?

It’s time for The CDC to take a back seat, put their tail in between their legs, and shut up.

They had one task, and they failed miserably on it. They failed America, and they failed the world since most governments are simply lapdogs of The United States government.

Here’s more on the story:

Here are the words appearing on the official website:

After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only.

CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.

Visit the FDA website for a list of authorized COVID-19 diagnostic methods. For a summary of the performance of FDA-authorized molecular methods with an FDA reference panel, visit this page.

In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test.

SIGN THE PETITION: Release The Epstein Client List!

CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses.

Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing.

ABC News featured CDC Director Rochelle Walensky’s recent comments:

“We do know that the most sensitive test you can do is a PCR test,” Walensky said. “So if you have symptoms and you have a negative antigen test, we do ask you to go and get a PCR to make sure those symptoms are not attributable to COVID.”


Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Hey, Noah here!

Wondering where we went?

Read this and bookmark our new site!

See you over there!

Thanks for sharing!